Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
Journal: Respiratory research
Published: October 24, 2025
Physiologically Based Biopharmaceutic Lung Deposition Modeling to Guide Clinical Device Transition of Protein A from a Nebulizer to a Dry Powder Inhaler.
Journal: Molecular pharmaceutics
Published: June 25, 2025
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported Outcomes.
Journal: Statistics in medicine
Published: July 29, 2024
Outcome of a Multi-modal CBT-based Treatment Program for Chronic School Refusal.
Journal: Global pediatric health
Published: April 15, 2021
A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 01, 2021
Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling.
Journal: International journal of chronic obstructive pulmonary disease
Published: October 14, 2020
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
Journal: American journal of respiratory and critical care medicine
Published: August 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284.
Journal: British journal of clinical pharmacology
Published: December 06, 2019
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trials.
Journal: Respiratory research
Published: October 17, 2019
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: April 10, 2018
Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects.
Journal: Clinical pharmacology and therapeutics
Published: December 21, 2017
A framework for mapping, visualisation and automatic model creation of signal-transduction networks.
A framework for mapping, visualisation and automatic model creation of signal-transduction networks.
Journal: Molecular systems biology
Published: April 26, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026